Former Spark exec to lead a gene therapy upstart of his own; Big Pharma marketing vet named CEO of Swiss biotech
→ Dave Greenwald’s days as acting CEO of Apertura Gene Therapy are over as Joseph La Barge steps in to lead …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
